Crimson Publishers Publish With Us Reprints e-Books Video articles

Abstract

Modern Approaches in Drug Designing

COVID-19 Vaccines

  • Open or CloseJagessar RC*

    Department of Chemistry, University of Guyana, Turkeyen Campus, Georgetown, Guyana, South America

    *Corresponding author:Jagessar RC, Department of Chemistry, University of Guyana, Turkeyen Campus, Georgetown, Guyana, South America

Submission: September 03, 2021; Published: September 14, 2021

ISSN : 2576-9170
Volume 3 Issue 4

Abstract

COVID-19 is a contagious disease induced by severe acute respiratory syndrome coronavirus 2, SARSCOV- 2. A possible mutant of SARS-COV-1. The disease has spread worldwide since, March 1, 2020, and then became a pandemic. All countries of the world have been affected. To date, there are 215,882,875 confirmed cases with 4,492,818 deaths. USA is the country with the greatest number of confirmed cases and most deaths, followed by our neighboring country Brazil. COVID-19 pandemic has been the impetus for the immediate use of antiviral drugs, such as chloroquine and Remdesivir, amongst others. The former was disapproved by FDA. However, the COVID-19 vaccine has been the only real solution to date, providing over 90% efficacy in all cases. Over 150 pharmaceutical companies are still pursuing research in order to find the best vaccine. Some of the vaccines currently being administered are Oxford Astrazenica, Sputnik-V, Moderna, Pfizer BioNTech, Sinopharm, Sinovac etc.

Keywords: COVID-19; Contagious disease; SARS-COV-2; USA; Oxford Astrazenica; Sputnik-V; Moderna

Get access to the full text of this article